ConductScience.org, home

Paper40721981

Mitochondrial bioenergetics and networks in melanoma: an update.

Giannitti G and 4 others. Apoptosis, 2025. Cited by 12 papers, by iCite.

Cite this record

ConductScience Library. Mitochondrial bioenergetics and networks in melanoma: an update. Papers, record 40721981. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40721981

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Mitochondrial bioenergetics and networks in melanoma: an update.
PubMed
Journal
Apoptosis
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
12
iCite
Relative citation ratio, by iCite
3.36, provisional
iCite
Revised in PubMed
2026-09-16
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Giannitti GGaia
2Paganoni AJJAlyssa Julia Jennifer
3Marchesi SSara
4Garavaglia RRiccardo
5Fontana FFabrizio

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MelanomaMajor topic
MitochondriaMajor topic
Energy MetabolismMajor topic
Skin NeoplasmsMajor topic
Humans
Apoptosis
Animals

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
Progetto di EccellenzaMinistero dell'Istruzione, dell'Università e della RicercaPubMed
PSR2023Università degli Studi di MilanoPubMed

Source PubMed

Download CSV of grants

Trials3

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT01989585Testing the Addition of Navitoclax to the Combination of Dabrafenib and Trametinib in People Who Have BRAF Mutant MelanomaDerived from the trialYesClinicalTrials.gov
NCT03311308A Trial of Pembrolizumab and Metformin Versus Pembrolizumab Alone in Advanced MelanomaDerived from the trialYesClinicalTrials.gov
NCT04114136Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor MalignanciesDerived from the trialYesClinicalTrials.gov

Download CSV of trials

References165

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127086916Use of a MCL-1 inhibitor alone to de-bulk melanoma and in combination to kill melanoma initiating cells.Oncotarget2017https://conductscience.org/library/papers/27086916PubMed
222295108A comparative study of gene-expression data of basal cell carcinoma and melanoma reveals new insights about the two cancers.PLoS One2012https://conductscience.org/library/papers/22295108PubMed
339817679Cancer statistics, 2025.CA Cancer J Clin2025https://conductscience.org/library/papers/39817679PubMed
430625226Synergistic antitumor effects of 9.2.27-PE38KDEL and ABT-737 in primary and metastatic brain tumors.PLoS One2019https://conductscience.org/library/papers/30625226PubMed
535203350Mitofusin-2 Negatively Regulates Melanogenesis by Modulating Mitochondrial ROS Generation.Cells2022https://conductscience.org/library/papers/35203350PubMed
624997364The role of melanogenesis in regulation of melanoma behavior: melanogenesis leads to stimulation of HIF-1α expression and HIF-dependent attendant pathways.Arch Biochem Biophys2014https://conductscience.org/library/papers/24997364PubMed
738812059Mitochondrial quality control in human health and disease.Mil Med Res2024https://conductscience.org/library/papers/38812059PubMed
810867810Antiapoptotic bcl-2 and bcl-xL in advanced malignant melanoma.Arch Dermatol Res2000https://conductscience.org/library/papers/10867810PubMed
927751856AMPK activation by GSK621 inhibits human melanoma cells in vitro and in vivo.Biochem Biophys Res Commun2016https://conductscience.org/library/papers/27751856PubMed
1036931258Omics-based approaches for the systematic profiling of mitochondrial biology.Mol Cell2023https://conductscience.org/library/papers/36931258PubMed
1125065405Mitochondrial dynamics regulate melanogenesis through proteasomal degradation of MITF via ROS-ERK activation.Pigment Cell Melanoma Res2014https://conductscience.org/library/papers/25065405PubMed
1235347324PGC-1α induced mitochondrial biogenesis in stromal cells underpins mitochondrial transfer to melanoma.Br J Cancer2022https://conductscience.org/library/papers/35347324PubMed
1337488586Exploring association of melanoma-specific Bcl-xL with tumor immune microenvironment.J Exp Clin Cancer Res2023https://conductscience.org/library/papers/37488586PubMed
1428489985Preclinical evaluation of the imipridone family, analogs of clinical stage anti-cancer small molecule ONC201, reveals potent anti-cancer effects of ONC212.Cell Cycle2017https://conductscience.org/library/papers/28489985PubMed
1538036770Mitophagy in human health, ageing and disease.Nat Metab2023https://conductscience.org/library/papers/38036770PubMed
1638424050Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) family in physiological and pathophysiological process and diseases.Signal Transduct Target Ther2024https://conductscience.org/library/papers/38424050PubMed
1731439581A Novel Mitochondrial Inhibitor Blocks MAPK Pathway and Overcomes MAPK Inhibitor Resistance in Melanoma.Clin Cancer Res2019https://conductscience.org/library/papers/31439581PubMed
1832021565A novel chalcone derivative has antitumor activity in melanoma by inducing DNA damage through the upregulation of ROS products.Cancer Cell Int2020https://conductscience.org/library/papers/32021565PubMed
1924429632Mitochondrial form and function.Nature2014https://conductscience.org/library/papers/24429632PubMed
2034205414Understanding the Central Role of Citrate in the Metabolism of Cancer Cells and Tumors: An Update.Int J Mol Sci2021https://conductscience.org/library/papers/34205414PubMed

See all 165 referencesDownload CSV of references

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.

PMIDTitleJournalYearIn PapersSource
42909325Mitochondrial remodeling in heart failure with reduced ejection fraction.Front Physiol2026https://conductscience.org/library/papers/42909325PubMed
42882458
Redox Storm in the Tumor Microenvironment (ΤΜΕ): Multifaceted Redox Injury and Immunometabolic Reprogramming Induced by Immune Checkpoint Blockade in B16F10 Melanoma: An Ultrastructural Study of the Peritumoral Interface.
Cells2026https://conductscience.org/library/papers/42882458PubMed
42795718Melanoma Intelligence: Explainable AI Reveals Histopathologic Aggressiveness as the Dominant Axis of Lymph-Node Metastasis.J Clin Med2026https://conductscience.org/library/papers/42795718PubMed
42737574Eriobotrya japonica (Loquat) Leaf Extract: An Integral In Vitro and In Ovo Approach to Antimelanoma Potential and Safety.Int J Mol Sci2026https://conductscience.org/library/papers/42737574PubMed
42653911The Plant Protease Inhibitor EcTI Suppresses Melanoma Progression In Vivo.Molecules2026https://conductscience.org/library/papers/42653911PubMed
42538580Phytochemical Characterization of Echeveria "Blue Curls" and Its Association With Redox-Metabolic Perturbations in Melanoma Cells.Chem Biodivers2026https://conductscience.org/library/papers/42538580PubMed
42353208Metformin Enhances 2-Aminoethyl Dihydrogen Phosphate-Induced Mitochondrial Dysfunction and Apoptosis in Melanoma Cells.Int J Mol Sci2026https://conductscience.org/library/papers/42353208PubMed
41897479Adipocyte-Derived Extracellular Vesicles Endow Melanoma Cells with Stem-like Traits via PGC-1α-Mediated Mitochondrial Reprogramming.Antioxidants (Basel)2026https://conductscience.org/library/papers/41897479PubMed
41751850Decoding the Role of Lipid Metabolism and Membrane Dynamics in Melanoma.Int J Mol Sci2026https://conductscience.org/library/papers/41751850PubMed
41751773Onconase Induces Apoptosis in Dabrafenib-Resistant Melanoma Cell Lines Through Dysregulation of ROS Homeostasis, Antioxidant Protein Expression, and Mitochondrial Dynamics.Int J Mol Sci2026https://conductscience.org/library/papers/41751773PubMed
41736012Mitophagy-driven multidimensional regulation of tumor immune evasion and context-dependent therapeutic strategies.J Transl Med2026https://conductscience.org/library/papers/41736012PubMed
41596686Lipidomics in Melanoma: Insights into Disease Progression and Therapeutical Targets.Int J Mol Sci2026https://conductscience.org/library/papers/41596686PubMed
41573726Mitochondrial dysfunction and apoptotic signaling induced by the combined action of 2-aminoethyl dihydrogen phosphate and methyl-β-cyclodextrin in melanoma cells.Front Pharmacol2025https://conductscience.org/library/papers/41573726PubMed
41463339The Neuro-Melanoma Singularity: Convergent Evolution of Neural and Melanocytic Networks in Brain Metastatic Adaptation.Biomolecules2025https://conductscience.org/library/papers/41463339PubMed
41179682Integrating single-cell transcriptomics and whole-genome CRISPR CAS9 screen identifies a cell cluster associated with tumor dependency in triple-negative breast cancer.Front Oncol2025https://conductscience.org/library/papers/41179682PubMed

Download CSV of cited by

Drugs7

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targetsSource
ROSIGLITAZONECHEMBL121Derived from the trial1https://conductscience.org/library/drugs/CHEMBL121ChEMBL
METFORMINCHEMBL1431Derived from the trial2https://conductscience.org/library/drugs/CHEMBL1431ChEMBL
DABRAFENIBCHEMBL2028663Derived from the trial1https://conductscience.org/library/drugs/CHEMBL2028663ChEMBL
TRAMETINIBCHEMBL2103875Derived from the trial1https://conductscience.org/library/drugs/CHEMBL2103875ChEMBL
NIVOLUMABCHEMBL2108738Derived from the trial1https://conductscience.org/library/drugs/CHEMBL2108738ChEMBL
PEMBROLIZUMABCHEMBL3137343Derived from the trial2https://conductscience.org/library/drugs/CHEMBL3137343ChEMBL
NAVITOCLAXCHEMBL443684Derived from the trial1https://conductscience.org/library/drugs/CHEMBL443684ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • Genes
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40721981

GET https://conductscience.org/api/papers/v1/40721981/references?page=2